Ohr Pharmaceutical Inc Contracts & Agreements
126 Contracts & Agreements
- Business Finance (63 contracts)
- Business Operations (1)
- Human Resources (26)
- Intellectual Property (2)
- Mergers & Acquisitions (4)
- Real Estate (10)
- Uncategorized (20)
- Certificate of Dissolution, as filed by NeuBase Therapeutics, Inc. with the Secretary of State of the State of Delaware, effective June 26, 2024 (Filed With SEC on June 27, 2024)
- Form of Subscription and Investment Representation Agreement, dated May 29, 2024 (Filed With SEC on May 31, 2024)
- Plan of Liquidation and Dissolution of NeuBase Therapeutics, Inc (Filed With SEC on March 7, 2024)
- Redemption and Termination Agreement, dated January 26, 2024, by and between NeuBase Therapeutics, Inc. and the Warrant Holder thereto (Filed With SEC on January 26, 2024)
- Lease Termination and Mutual Release Agreement, dated December 27, 2023, by and between NeuBase Therapeutics, Inc. and 350 Technology Drive Partners, LLC (Filed With SEC on December 28, 2023)
- Bill of Sale, dated December 27, 2023, entered into by NeuBase Therapeutics, Inc. for the benefit of University of Pittsburgh of the Commonwealth System of Higher Education (Filed With SEC on December 28, 2023)
- Form of Series A-1 Common Stock Purchase Warrant (Filed With SEC on October 18, 2023)
- Exchange Agreement, dated October 17, 2023, by and between NeuBase Therapeutics, Inc. and the Warrant Holder thereto (Filed With SEC on October 18, 2023)
- Amendment No. 1 to NeuBase Therapeutics, Inc. 2019 Stock Incentive Plan (Filed With SEC on July 31, 2023)
- Form of Series A Common Stock Purchase Warrant (Filed With SEC on June 30, 2023)
- Form of Series B Common Stock Purchase Warrant (Filed With SEC on June 30, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Registered Direct Offering) (Filed With SEC on June 30, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (PIPE Private Placement) (Filed With SEC on June 30, 2023)
- Form of Placement Agent Common Stock Purchase Warrant (Filed With SEC on June 30, 2023)
- Securities Purchase Agreement, dated June 28, 2023 (Registered Direct Offering) (Filed With SEC on June 30, 2023)
- Securities Purchase Agreement, dated June 28, 2023 (PIPE Private Placement) (Filed With SEC on June 30, 2023)
- Registration Rights Agreement, dated June 28, 2023 (Filed With SEC on June 30, 2023)
- Purchase Agreement, dated December 28, 2022, by and between NeuBase Therapeutics, Inc. and Alumni Capital LP (Filed With SEC on December 29, 2022)
- Amendment #1 to License Agreement, dated January 1, 2022, by and between NeuBase Therapeutics, Inc. and Carnegie Mellon University (Filed With SEC on December 21, 2022)
- Outside Director Compensation Policy (Filed With SEC on September 12, 2022)
- Offer Letter of Employment, effective January 10, 2022, by and between NeuBase Therapeutics, Inc. and Todd Branning (Filed With SEC on January 10, 2022)
- Separation Agreement and General Release, dated September 30, 2021, by and between Sam Backenroth and NeuBase Therapeutics, Inc (Filed With SEC on October 1, 2021)
- Open Market Sale AgreementSM dated August 27, 2021, by and between NeuBase Therapeutics, Inc. and Jefferies LLC (Filed With SEC on August 27, 2021)
- Offer Letter of Employment, dated May 17, 2021, by and between NeuBase Therapeutics, Inc. and Kia Motesharei (Filed With SEC on May 25, 2021)
- Offer Letter of Employment, effective May 17, 2021, by and between NeuBase Therapeutics, Inc. and Sandra Rojas-Caro (Filed With SEC on May 20, 2021)
- Second Amendment to Lease Agreement, dated April 21, 2021, by and between NeuBase Therapeutics, Inc. and 350 Technology Drive Partners, LLC (Filed With SEC on April 27, 2021)
- Underwriting Agreement, dated as of April 22, 2021, by and among NeuBase Therapeutics, Inc. and RBC Capital Markets, LLC, Oppenheimer & Co. Inc. and Chardan Capital Markets LLC,... (Filed With SEC on April 22, 2021)
- First Amendment to Lease Agreement, dated December 28, 2020 (Filed With SEC on February 11, 2021)
- Amendment No. 4 to Sublease Agreement, dated as of August 20, 2020 (Filed With SEC on December 23, 2020)
- Amendment No. 5 to Sublease Agreement, dated as of September 25, 2020 (Filed With SEC on December 23, 2020)
- Lease Agreement, dated as of October 2, 2020, by and between NeuBase Therapeutics, Inc. and 350 Technology Drive Partners, LLC (Filed With SEC on December 23, 2020)
- Offer Letter of Employment, dated November 30, 2020, by and between NeuBase Therapeutics, Inc. and Curt Bradshaw (Filed With SEC on December 2, 2020)
- Outside Director Compensation Policy (Filed With SEC on September 11, 2020)
- Offer Letter of Employment, dated July 22, 2020, by and between NeuBase Therapeutics, Inc. and William Mann (Filed With SEC on July 28, 2020)
- Underwriting Agreement, dated as of April 28, 2020, by and between NeuBase Therapeutics, Inc. and Oppenheimer & Co. Inc. and BTIG, LLC, as representatives of the underwriters... (Filed With SEC on April 29, 2020)
- Lease Extension to Sublease Agreement, dated as of February 26, 2020, by and between NeuBase Therapeutics, Inc. and StartUptown dba Avenu (Filed With SEC on March 26, 2020)
- Description of Securities of NeuBase Therapeutics, Inc (Filed With SEC on January 10, 2020)
- Sublease Agreement, dated as of March 12, 2019, by and between NeuBase Therapeutics, Inc. and StartUptown dba Avenu (Filed With SEC on January 10, 2020)
- Amendment No. 1 to Sublease Agreement, dated as of May 21, 2019, by and between NeuBase Therapeutics, Inc. and StartUptown dba Avenu (Filed With SEC on January 10, 2020)
- Amendment No. 2 to Sublease Agreement, dated as of July 29, 2019, by and between NeuBase Therapeutics, Inc. and StartUptown dba Avenu (Filed With SEC on January 10, 2020)
- Offer of Employment, dated July 11, 2019, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan (Filed With SEC on July 17, 2019)
- Common Stock Purchase Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signatures pages thereto (Filed With SEC on July 12, 2019)
- Registration Rights Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signature pages thereto (Filed With SEC on July 12, 2019)
- First Amendment, dated as of June 27, 2019, to the Agreement and Plan of Merger and Reorganization, dated as of January 2, 2019, by and among Ohr Pharmaceutical, Inc., Ohr... (Filed With SEC on July 3, 2019)
- License Agreement, dated December 17, 2018, by and between NeuBase Therapeutics, Inc., and Carnegie Mellon University (Filed With SEC on March 8, 2019)
- Form of NeuBase Therapeutics, Inc. Warrant Certificate (Filed With SEC on March 8, 2019)
- Form of NeuBase Therapeutics, Inc. Note Purchase Agreement (Filed With SEC on March 8, 2019)
- Form of NeuBase Therapeutics, Inc. Convertible Promissory Note (Filed With SEC on March 8, 2019)
- NeuBase Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 8, 2019)
- Form of Option Agreement under NeuBase Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 8, 2019)
- Restricted Stock Purchase Agreement, made as of September 6, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan (Filed With SEC on March 8, 2019)
- Amendment to Restricted Stock Purchase Agreement, made as of December 26, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan (Filed With SEC on March 8, 2019)
- Form of Support Agreement, by and among Ohr Pharmaceutical, Inc., NeuBase Therapeutics, Inc. and the directors and officers of Ohr Pharmaceutical, Inc (Filed With SEC on January 3, 2019)
- Form of Support Agreement, by and among NeuBase Therapeutics, Inc., Ohr Pharmaceutical, Inc. and its directors, officers and certain stockholders of NeuBase Therapeutics, Inc (Filed With SEC on January 3, 2019)
- Form of Company and NeuBase Lock-Up Agreements (Filed With SEC on January 3, 2019)
- Retention Bonus Agreement, by and between Ohr Pharmaceutical, Inc. and Dr. Jason Slakter (Filed With SEC on January 3, 2019)
- Agreement and Plan of Merger and Reorganization, dated January 2, 2019, by and among Ohr Pharmaceutical, Inc., Ohr Acquisition Corp., and NeuBase Therapeutics, Inc (Filed With SEC on January 3, 2019)
- Form of Stock Option Agreement (Filed With SEC on December 15, 2017)
- Form of Restricted Stock Agreement (Filed With SEC on December 15, 2017)
- Separation Agreement, dated as of May 12, 2017, between Ohr Pharmaceutical, Inc. and Ira Greenstein (Filed With SEC on May 12, 2017)
- Form of Warrant (Filed With SEC on April 6, 2017)
- Securities Purchase Agreement dated as of April 5, 2017, by and among Ohr Pharmaceutical, Inc. and the purchasers listed therein (Filed With SEC on April 6, 2017)
- Placement Agent Agreement dated as of April 5, 2017, by and among Ohr Pharmaceutical, Inc., Chardan Capital Markets, LLC and H.C. Wainwright & Co., LLC (Filed With SEC on April 6, 2017)
- Form of Warrant (Filed With SEC on April 4, 2017)
- Form of Securities Purchase Agreement (Filed With SEC on April 4, 2017)
- Form of Series A Warrant (Filed With SEC on December 8, 2016)
- Form of Series B Warrant (Filed With SEC on December 8, 2016)
- Securities Purchase Agreement, dated December 7, 2016, by and among Ohr Pharmaceutical, Inc. and the purchasers listed therein (Filed With SEC on December 8, 2016)
- Letter Agreement, dated December 2, 2016, by and between Ohr Pharmaceutical, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 8, 2016)
- Consulting Agreement and Release, dated December 11, 2015, between Ohr Pharmaceutical, Inc. and Irach B. Taraporewala (Filed With SEC on December 14, 2015)
- Restricted Stock Agreement, dated December 11, 2015, between Ohr Pharmaceutical, Inc. and Irach B. Taraporewala (Filed With SEC on December 14, 2015)
- Lock-up Agreement, dated December 11, 2015, from Irach B. Taraporewala (Filed With SEC on December 14, 2015)
- Proprietary Information and Invention Agreement, dated April 10, 2010, between Ohr Pharmaceutical, Inc. and Irach B. Taraporewala (Filed With SEC on December 14, 2015)
- Proprietary Information and Inventions Agreement, dated April 10, 2010, between Ohr Pharmaceutical, Inc. and Sam Backenroth (Filed With SEC on December 14, 2015)
- Amendment to The 2014 Stock Incentive Plan (Filed With SEC on December 14, 2015)
- Form of Stock Option (Filed With SEC on May 11, 2015)
- 2014 Stock Incentive Plan, as amended (Filed With SEC on March 13, 2015)
- Underwriting Agreement, dated February 6, 2015, by and between Ohr Pharmaceutical, Inc. and Cowen and Company, LLC, as representative of the Underwriters named therein (Filed With SEC on February 6, 2015)
- Amendment No. 1 to Warrant Agreement, dated January 15, 2015 (Filed With SEC on January 20, 2015)
- Amendment, dated January 6, 2015, to Taraporewala employment agreement (Filed With SEC on January 8, 2015)
- Amendment, dated January 6, 2015, to Backenroth employment agreement (Filed With SEC on January 8, 2015)
- Second Research Agreement, July 31, 2013 (Filed With SEC on August 18, 2014)
- Agreement and Plan of Merger, dated as of May 30, 2014, among Ohr Pharmaceutical, Inc. (renamed Ohr Opco, Inc.), Ohr Holdco, Inc. (renamed Ohr Pharmaceutical, Inc.) and Ohr Merger... (Filed With SEC on June 2, 2014)
- Assignment and Assumption Agreement between Ohr Pharmaceutical, Inc. and Ohr Holdco, Inc., dated May 30, 2014 (Filed With SEC on June 2, 2014)
- Contribution Agreement (Filed With SEC on May 16, 2014)
- 2014 Stock Incentive Plan (Filed With SEC on April 14, 2014)
- Placement Agency Agreement, dated April 8, 2014, by and among Ohr Pharmaceutical, Inc., Chardan Capital Markets, LLC and Brean Capital, LLC (Filed With SEC on April 8, 2014)
- Form of Subscription Agreement, dated April 8, 2014, by and among Ohr Pharmaceutical, Inc. and each of the investors (Filed With SEC on April 8, 2014)
- Amendment No. 1 to Warrant Agreement, dated March 11, 2014 (Filed With SEC on March 14, 2014)
- Employment Agreement with Dr. Taraporewala, dated January 8, 2014 (Filed With SEC on January 10, 2014)
- Employment Agreement with Mr. Backenroth, dated January 8, 2014 (Filed With SEC on January 10, 2014)
- Employment Agreement with Irach Taraporewala, dated August 9, 2013 (Filed With SEC on August 13, 2013)
- Employment Agreement with Sam Backenroth, dated August 9, 2013 (Filed With SEC on August 13, 2013)
- Compensation Committee Charter Adopted on June 13, 2013 (Filed With SEC on June 19, 2013)
- Audit Committee Charter (Filed With SEC on May 24, 2013)
- Notice to Series B Warrant Holders, Dated April 5, 2013 (Filed With SEC on April 22, 2013)
- Amendment 3 to Warrant Agreement, Dated April 18, 2013 (Filed With SEC on April 22, 2013)
- Amendment No. 2 to Warrant Agreement, dated October 31, 2012 (Filed With SEC on November 1, 2012)
- OHR PHARMACEUTICAL, INC. CLASS A PURCHASE WARRANT (Filed With SEC on July 3, 2012)
- OHRPHARMACEUTICAL INC. STOCKOPTION AGREEMENT (Filed With SEC on March 15, 2012)
- EMPLOYMENTAGREEMENT (Filed With SEC on March 15, 2012)
- Form of Subscription Agreement Dated December 16, 2011 by and between the Company and the Investors in the Private Placement (Filed With SEC on December 20, 2011)
- Form of Class J Common Stock Purchase Warrant issued pursuant to the Subscription Agreement, dated as of December 16, 2011 (Filed With SEC on December 20, 2011)
- Form of Warrant Agreement, dated October 31, 2006 (Filed With SEC on November 2, 2011)
- Amendment No. 1 to Warrant Agreement, dated October 31, 2011 (Filed With SEC on November 2, 2011)
- OHR PHARMACEUTICAL, INC. COMMON STOCK PURCHASE WARRANT Warrant No. [][] Warrants VOID AFTER 5:00 P.M. NEW YORK CITY TIME ON [] (Filed With SEC on August 15, 2011)
- Form of Class H Common Stock Purchase Warrant issued pursuant to the warrant exercise agreement, dated as of January 15, 20108 (Filed With SEC on January 13, 2011)
- Form of Subscription Agreement Dated December 30, 2010 by and between the Company and the investors in the Private Placement (Filed With SEC on January 5, 2011)
- Form of Class I Common Stock Purchase Warrant issued pursuant to the Subscription Agreement, dated as of December 30, 2010 (Filed With SEC on January 5, 2011)
- Material Contract, 2009 Employee Stock Options Plan (Filed With SEC on May 17, 2010)
- OhrPharmaceutical, Inc 1245Brickyard Road, #590 Salt lakeCity, Utah 84106 801-433-2000ph 801-433-2222fx (Filed With SEC on April 12, 2010)
- OhrPharmaceutical, Inc (Filed With SEC on April 12, 2010)
- Material Contract (Filed With SEC on February 16, 2010)
- ASSETPURCHASE AGREEMENT datedAugust 21, 2009 between OHRPHARMACEUTICAL, INC. and GENAERALIQUIDATING TRUST (Filed With SEC on August 26, 2009)
- MERGERAGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on August 11, 2009)
- BBMHOLDINGS, INC. UNITSUBSCRIPTION AGREEMENT SERIESB CONVERTIBLE PREFERRED STOCK AND WARRANTS (Filed With SEC on June 3, 2009)
- BBMHOLDINGS, INC. CLASS FREDEEMABLE PURCHASE WARRANT (Filed With SEC on June 3, 2009)
- BBMHOLDINGS, INC. CLASS GPURCHASE WARRANT (Filed With SEC on June 3, 2009)
- BBMHOLDINGS, INC. COMMONSTOCK PURCHASE WARRANT (Filed With SEC on June 3, 2009)
- FIRSTAMENDMENT TO AGREEMENTFOR PURCHASE AND SALE OF ASSETS (Filed With SEC on January 13, 2009)
- CONSULTING AGREEMENT (Filed With SEC on November 12, 2008)
- AGREEMENT FOR PURCHASE AND SALE OF ASSETS by and between BBM HOLDINGS, INC. (Buyer) and SHALOM HIRSCHMAN (Seller) November 12, 2008 TABLE OF CONTENTS (Filed With SEC on November 12, 2008)
- BBM HOLDINGS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on November 12, 2008)
- BBM HOLDINGS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 12, 2008)
- ASSET PURCHASE AGREEMENT dated as of October 16, 2007 among VSAT BROADBAND INDUSTRIES, INC. CONTAINER RADIO SERVICES S.A., BBM HOLDINGS, INC., and BROADBAND MARITIME, INC. ASSET... (Filed With SEC on October 17, 2007)
- BBM HOLDINGS, INC. AND COTTONWOOD STOCK TRANSFER ___________________________ WARRANT AGREEMENT Dated as of October 15, 2007 (Filed With SEC on October 17, 2007)
